English Site Map I care about my health No Prescription Interesting Links Quotations from 2009-02-27 16:20:02 openings: 16.13 / last: 16.00 / min: 15.80 / max: 16.35 Home About company Market Position Management board of directors Organizational structure Company data Corporate film For customers GAME info Distribution structure Distribution regions I care about my health For media Press releases gallery For Investors Shareholding Calendar Current reports Financial reports Annual Reports Issue prospectuses Analysts about PGF Press about PGF Presentations Quotations contact Corporate Governance Management board of directors Statute Code of good practice Regulations AGM Tenders and Announcements Tenders Real estate job Form Job offers Offers for Pharmacists Internship / Internship contact Search Home Recent events Purchase of PGF SA bonds by a subsidiary 11/2009 of February 23, 2009 (Added: 2009-02-23) Report: Current Registration of a subsidiary on 10/2009 of February 18, 2009. (Added: 2009-02-18) Report: Current Purchase of PGF SA bonds by a subsidiary 9/2009 dated February 12, 2009 (Added: 2009-02-12) Report: Current Increase of capital in a subsidiary 8/2009 of February 11, 2009 (Added: 2009-02-11) Report: Current Purchase of PGF SA bonds by a subsidiary 7/2009 of February 4, 2009 (Added: 2009-02-04) Report: Current Welcome! When in 1997 Polska Grupa Farmaceutyczna (then still operating under the name of Medicines), as the first company in the industry, introduced its shares to the Warsaw Stock Exchange, we promised active participation in the inevitable process of consolidation of the pharmaceutical wholesale market. We have kept this promise. The funds obtained thanks to the trust placed in us by investors allowed us to set directions that were later followed by others. Today, Polska Grupa Farmaceutyczna has over 20% share in the domestic pharmaceutical distributors market and is its undisputed leader. Behind this figure, however, there is more than just the value of the turnover generated. The capital acquired on the public market allowed us to set directions for development not only in terms of market consolidation, but also in terms of services provided on it. PGF's permanent commercial offer includes approximately 18,000 assortment items, which, combined with the optimized nationwide distribution network, allows us to present an offer that is unavailable to most competitors. Despite these undeniable successes, we do not succumb to the magic of numbers. Each client is important to us all the time. The fight for market share and the quality of services offered does not obscure the main goal of each commercial company - the increase in profit to be distributed among shareholders, as evidenced by the achieved financial results. Last transaction: 2009-02-27 16:20:02 | Last document: 2009-02-23 | Last report: 2009-02-23 Disclaimer © 2006 Polska Grupa Farmaceutyczna SA